PO-0619: Comparison of a nanoString and RNA microarray gene signature predicting LRC after PORT-C in HNSCC

Authors :: Schmidt, S.
Linge, A.
Zwanenburg, A.
Leger, S.
Lohaus, F.
Gudziol, V.
Nowak, A.
Tinhofer, I.
Budach, V.
Sak, A.
Stuschke, M.
Balermpas, P.
Rödel, C.
Grosu, A. L.
Abdollahi, A.
Debus, J.
Belka, C.
Combs, S. E.
Mönnich, D.
Zips, D.
Baretton, G. B.
Buchholz, F.
Baumann, M.
Krause, M.
Löck, S.
Schmidt, S.
Linge, A.
Zwanenburg, A.
Leger, S.
Lohaus, F.
Gudziol, V.
Nowak, A.
Tinhofer, I.
Budach, V.
Sak, A.
Stuschke, M.
Balermpas, P.
Rödel, C.
Grosu, A. L.
Abdollahi, A.
Debus, J.
Belka, C.
Combs, S. E.
Mönnich, D.
Zips, D.
Baretton, G. B.
Buchholz, F.
Baumann, M.
Krause, M.
Löck, S.
Source :: Radiotherapy and Oncology 123(2017), S323-S324
Publication Year :: 2017
Abstract: A gene signature predicting loco-regional control (LRC) of locally advanced head and neck squamous cell carcinoma (HNSCC) after postoperative radiochemotherapy (PORTC) will be evaluated using nanoString and RNA microarray data. The prognostic power of the signature as well as the correlation between both methods is evaluated to underline the robustness of the proposed signature.

Tools